Deep Medicine Acquisition Corp (DMAQ) Peer Comparison
$2.98
$-5.41
(-64.48%)
As on 31-Jan-2024 19:59EDT
Market cap
$13 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
22
Div. Yield
0 %
Edit
| Deep Medicine Acquisition Corp (DMAQ) | MFS High Income Municipal Closed Fund (CXE) | MFS High Yield Municipal Closed Fund (CMU) | MFS Investment Grade Municipal Trust (CXH) | Bank of New York Mellon (BK) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
13 | 115 | 86 | 31 | 94,144 |
Revenue ($ Mln) |
0 | 3 | 6 | 5 | 40,653 |
Net Profit ($ Mln) |
-1.55 | 0.08 | -0.02 | 0.11 | 5,961.00 |
Net Margin (%) |
-1,721.63 | 48.57 | 48.93 | 22.52 | 14.66 |
RoE (%) |
-- | 0.06 | -0.02 | 0.16 | 13.38 |
Price to Earnings |
-- | 365.00 | -- | 381.50 | 17.02 |
Price-To-Book |
22.01 | 0.88 | 0.89 | 0.44 | 2.48 |
Income Statement ($ Mln)
| Deep Medicine Acquisition Corp (DMAQ) | MFS High Income Municipal Closed Fund (CXE) | MFS High Yield Municipal Closed Fund (CMU) | MFS Investment Grade Municipal Trust (CXH) | Bank of New York Mellon (BK) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
0.00 | 2.45 | 1.64 | 1.86 | 33,791.00 |
|
Cost of Revenue
|
0.06 | 1.37 | 1.28 | 0.74 | 16,422.00 |
|
Gross Profit
|
-0.06 | 2.45 | 1.64 | 1.86 | 17,369.00 |
|
Operating Expenses
|
2.11 | 0.00 | 0.37 | 0.29 | 13,086.00 |
|
Operating Profit (EBIT)
|
-0.34 | 2.45 | 1.27 | 1.57 | 4,283.00 |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
-0.34 | 2.45 | 1.27 | 1.57 | 4,283.00 |
|
Provision for Tax
|
0.06 | 4.89 | 3.75 | 2.27 | 979.00 |
|
Profit after Tax (Net Income)
|
-0.40 | 2.45 | 1.27 | 1.57 | 3,302.00 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-0.40 | -34.27 | -27.75 | -18.34 | 3,051.00 |
Liabilities ($ Mln)
| Deep Medicine Acquisition Corp (DMAQ) | MFS High Income Municipal Closed Fund (CXE) | MFS High Yield Municipal Closed Fund (CMU) | MFS Investment Grade Municipal Trust (CXH) | Bank of New York Mellon (BK) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
2.55 | 126.26 | 92.99 | 68.80 | 40,770.00 |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
4.43 | 81.46 | 59.97 | 43.77 | 49,858.00 |
|
Current Liabilities
|
2.80 | 2.52 | 1.95 | 1.63 | 319,114.00 |
|
Total Liabilities
|
9.78 | 210.33 | 155.01 | 114.47 | 409,877.00 |
Assets ($ Mln)
| Deep Medicine Acquisition Corp (DMAQ) | MFS High Income Municipal Closed Fund (CXE) | MFS High Yield Municipal Closed Fund (CMU) | MFS Investment Grade Municipal Trust (CXH) | Bank of New York Mellon (BK) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
0.00 | 206.52 | 152.79 | 112.78 | 159,810.00 |
|
Current Assets
|
9.78 | 4.04 | 2.75 | 1.68 | 250,067.00 |
|
Total Assets
|
9.78 | 210.33 | 155.01 | 114.47 | 409,877.00 |
|
Total Debt*
|
1.87 | 81.46 | 59.97 | 43.77 | 46,243.00 |
|
Net Current Assets
|
6.98 | -- | -- | -- | -- |
Cashflow ($ Mln)
| Deep Medicine Acquisition Corp (DMAQ) | MFS High Income Municipal Closed Fund (CXE) | MFS High Yield Municipal Closed Fund (CMU) | MFS Investment Grade Municipal Trust (CXH) | Bank of New York Mellon (BK) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-1.04 | 10.00 | 23.14 | 11.84 | 5,912.00 |
|
Cash Flow from Investing Activities
|
120.42 | 6.30 | 17.63 | 7.03 | -5,810.00 |
|
Cash from Financing Activities
|
-119.67 | -10.00 | -23.14 | -11.84 | -3,519.00 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Deep Medicine Acquisition Corp (DMAQ) | MFS High Income Municipal Closed Fund (CXE) | MFS High Yield Municipal Closed Fund (CMU) | MFS Investment Grade Municipal Trust (CXH) | Bank of New York Mellon (BK) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-0.62 | 1.16 | 0.77 | 1.31 | 3.30 |
|
ROE (%)
|
-0.63 | 1.92 | 1.28 | 2.16 | 8.09 |
|
ROA (%)
|
-0.58 | 1.15 | 0.77 | 1.29 | 0.81 |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-- | 99.96 | 77.39 | 84.47 | 9.77 |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Deep Medicine Acquisition Corp (DMAQ) | MFS High Income Municipal Closed Fund (CXE) | MFS High Yield Municipal Closed Fund (CMU) | MFS Investment Grade Municipal Trust (CXH) | Bank of New York Mellon (BK) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | 1.07 | 1.06 | 1.10 | 0.71 |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
-11.74 | 107.15 | 104.56 | 108.58 | 29.19 |
|
EPS Growth (%)
|
-- | -- | -- | -- | 0.37 |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Deep Medicine Acquisition Corp (DMAQ) | MFS High Income Municipal Closed Fund (CXE) | MFS High Yield Municipal Closed Fund (CMU) | MFS Investment Grade Municipal Trust (CXH) | Bank of New York Mellon (BK) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-- | -- | -- | -- | 12.17 |
|
Price / Book Value
|
-- | -- | -- | -- | 0.99 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
1.98 | 33.13 | 47.14 | 27.83 | -24.72 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Deep Medicine Acquisition Corp (DMAQ) | MFS High Income Municipal Closed Fund (CXE) | MFS High Yield Municipal Closed Fund (CMU) | MFS Investment Grade Municipal Trust (CXH) | Bank of New York Mellon (BK) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.73 | 0.65 | 0.64 | 0.64 | 1.13 |
|
Short term debt to equity ratio
|
0.73 | 0.00 | -- | -- | 0.36 |
|
Current Ratio
|
3.50 | 1.60 | 1.41 | 1.03 | 0.78 |
|
Quick Ratio
|
-- | -- | -- | -- | 0.45 |
|
Interest Coverage
|
-55.85 | 0.65 | 0.42 | 0.74 | 0.26 |
Operating Efficiency Ratios
| Deep Medicine Acquisition Corp (DMAQ) | MFS High Income Municipal Closed Fund (CXE) | MFS High Yield Municipal Closed Fund (CMU) | MFS Investment Grade Municipal Trust (CXH) | Bank of New York Mellon (BK) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | 163.45 | 152.10 | 90.12 | 25.41 |
|
Asset Turnover
|
0.00 | 0.01 | 0.01 | 0.02 | 0.08 |
|
Receivable days
|
-- | 578.77 | 613.71 | 338.74 | 51.04 |
|
Inventory Days
|
-- | -- | -- | 0.00 | -478.67 |
|
Payable days
|
-- | 454.66 | 375.79 | 571.73 | 465.18 |
|
Cash Conversion Cycle
|
-- | -- | -- | -521.59 | -892.82 |
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
